Jim Cramer Talked About These 7 Stocks Recently

4. Abbott Laboratories (NYSE:ABT)

Number of Hedge Fund Holders: 66

A caller asked why Abbott Laboratories’ (NYSE:ABT) forward PE was higher than its current and trailing PE. Here’s what Cramer had to say in response:

“Okay, their forward PE shows that there’s going to be a, pretty much of an earnings explosion. And I think a lot of that’s going to be coming from Libre, which is their diabetes, they have the best diabetes device. It’s cheaper than everybody’s.

By the way, I think pound for pound, it’s better than Dexcom, and Dexcom stock was up very big today. Also, remember, Robert Ford runs Abbott, and he runs it incredibly well. And I also think they’re going to settle these lawsuits or win the lawsuits that have really kept the lid on the stock, and that’s going to happen in 2025.”

Abbott Laboratories (NYSE:ABT) is a healthcare company that focuses on the research, development, manufacturing, and marketing of various medical products.